Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to ...

Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive.

While sifting through the juvenile mammoth’s genetic materials for traces of RNA, the team made another surprising discovery: ...

It must be aggressive enough to fight infections and cancer, yet restrained enough to avoid attacking the body's own tissues.

The immune system faces a delicate balancing act: it must be aggressive enough to fight infections and cancer, yet restrained ...

A vocal minority of finasteride users speak out about the long-lasting mental side effects of the hair loss drug, as ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Discover insights on Insight Molecular Diagnostics Inc.'s GraftAssureDx, FDA prospects, and market potential. Click for more ...